BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18656936)

  • 1. Lignans isolated from Campylotropis hirtella (Franch.) Schindl. decreased prostate specific antigen and androgen receptor expression in LNCaP cells.
    Han HY; Wang XH; Wang NL; Ling MT; Wong YC; Yao XS
    J Agric Food Chem; 2008 Aug; 56(16):6928-35. PubMed ID: 18656936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sesquilignans and dilignans from Campylotropis hirtella (Franch.) Schindl.
    Han HY; Liu HW; Wang NL; Yao XS
    Nat Prod Res; 2008; 22(11):984-989. PubMed ID: 18629715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cells.
    Thelen P; Peter T; Hünermund A; Kaulfuss S; Seidlová-Wuttke D; Wuttke W; Ringert RH; Seseke F
    BJU Int; 2007 Jul; 100(1):199-203. PubMed ID: 17488304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coumarins from campylotropis hirtella (FRANCH.) SCHINDL. and their inhibitory activity on prostate specific antigen secreted from LNCaP cells.
    Han HY; Wen P; Liu HW; Wang NL; Yao XS
    Chem Pharm Bull (Tokyo); 2008 Sep; 56(9):1338-41. PubMed ID: 18758115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
    Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ
    Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of PSA secretion and survival signaling by calcium-independent phopholipase A(2)beta in prostate cancer cells.
    Nicotera TM; Schuster DP; Bourhim M; Chadha K; Klaich G; Corral DA
    Prostate; 2009 Sep; 69(12):1270-80. PubMed ID: 19475654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piper cubeba targets multiple aspects of the androgen-signalling pathway. A potential phytotherapy against prostate cancer growth?
    Yam J; Kreuter M; Drewe J
    Planta Med; 2008 Jan; 74(1):33-8. PubMed ID: 18080233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro.
    McCann MJ; Gill CI; Linton T; Berrar D; McGlynn H; Rowland IR
    Mol Nutr Food Res; 2008 May; 52(5):567-80. PubMed ID: 18398867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of prostate specific antigen in LNCaP cells by flavonoids from the pollen of Brassica napus L.
    Han HY; Shan S; Zhang X; Wang NL; Lu XP; Yao XS
    Phytomedicine; 2007 May; 14(5):338-43. PubMed ID: 17085029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.
    Tsui KH; Feng TH; Lin CM; Chang PL; Juang HH
    J Androl; 2008; 29(6):661-8. PubMed ID: 18676361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
    Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors.
    Snoek R; Cheng H; Margiotti K; Wafa LA; Wong CA; Wong EC; Fazli L; Nelson CC; Gleave ME; Rennie PS
    Clin Cancer Res; 2009 Jan; 15(1):39-47. PubMed ID: 19118031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
    Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
    Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells.
    Bass R; Perry B; Langenstroer P; Thrasher JB; Dennis KL; Tawfik O; Holzbeierlein J
    J Urol; 2009 Feb; 181(2):615-9; discussion 619-20. PubMed ID: 19091346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells.
    Lee DH; Szczepanski MJ; Lee YJ
    J Cell Biochem; 2009 Apr; 106(6):1113-22. PubMed ID: 19229860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer.
    Das K; Cheah PY; Lim PL; Zain YB; Stephanie FC; Zhao Y; Cheng C; Lau W
    Cancer Lett; 2008 Sep; 268(2):340-7. PubMed ID: 18495332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of prostate cancer from hormone independency to dependency due to AMACR inhibition: involvement of increased AR expression and decreased IGF1 expression.
    Takahara K; Azuma H; Sakamoto T; Kiyama S; Inamoto T; Ibuki N; Nishida T; Nomi H; Ubai T; Segawa N; Katsuoka Y
    Anticancer Res; 2009 Jul; 29(7):2497-505. PubMed ID: 19596919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
    Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
    Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M
    Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.